Australia markets open in 10 hours

CG Jan 2025 17.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 03:29PM EDT. Market open.
Full screen
Previous close0.0500
Open0.0500
Bid0.0000
Ask0.7500
Strike17.50
Expiry date2025-01-17
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume13
Open interest126
  • Zacks

    Carlyle Group (CG) Eyes Buyout of Baxter's Kidney Care Unit

    Carlyle Group (CG) is in talks to acquire Baxter's kidney care unit. The companies started exclusive negotiations in late June and an agreement could be announced as soon as this week.

  • GlobeNewswire

    Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

    £90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova PartnersFunds will be used to build out Myricx Bio’s proprietary N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform and advance its pipeline of NMTi-ADCs through clinical proof of concept targeting clinically val

  • Reuters

    Carlyle in talks to buy Baxter's kidney care unit, source says

    Shares of the Deerfield, Illinois-based firm rose more than 4%. Medical device maker Baxter said in March it had been in discussions with select private equity investors to explore a potential sale of the kidney care unit more than a year after it announced plans to separate the unit amid supply-chain challenges and weak demand for dialysis operations. Baxter declined to comment while Carlyle did not immediately respond to a Reuters request for comment.